Table 2. Prevalence of enthesopathic changes in plantar fascia from patients and controls.
| T2DM (N = 100) | Controls (N = 100) | P value | |
|---|---|---|---|
| PF enthesis thickness, mm | 3.7 ± 0.9 | 3.0 ± 0.6 | < .0001 |
| Hypoechogenicity, % | 6 | 1 | .12 |
| Thickening, % | 12 | 1 | .002 |
| Calcification, % | 2 | 0 | .50 |
| Enthesophyte, % | 28 | 14 | .02 |
| Bony erosion, % | 0 | 0 | 1.00 |
| Bony irregularity, % | 19 | 7 | .02 |
| Bursitis, % | 1 | 0 | 1.00 |
| Tear, % | 0 | 0 | 1.00 |
| Power-Doppler, % | 0 | 0 | 1.00 |
| Sum of abnormalities, n | 0 (0.5–0.9) | 0 (0.1–0.3) | < .0001 |
| Bilateral involvement, %* | 16 (32) | 4 (8) | .005 |
Legend: PF, plantar fascia; T2DM, type 2 diabetes mellitus. * Data are relative to the total patients number (not tendons).Data are presented as mean ± standard deviation, median (25th– 75th percentile), or number (percentage) as appropriate.